Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 318,183 | 311,332 | 304,416 | 305,301 | 297,485 |
| Cost of Goods | 147,673 | 144,067 | 148,167 | 146,594 | 139,607 |
| Gross Profit | 170,510 | 167,265 | 156,249 | 158,707 | 157,878 |
| Operating Expenses | 135,880 | 113,673 | 121,161 | 116,022 | 111,753 |
| Operating Income | 35,303 | 53,659 | 35,255 | 43,279 | 46,732 |
| Interest Expense | 2,471 | 0 | 2,629 | 1,055 | 5,673 |
| Other Income | 0 | -2,069 | 0 | 0 | 0 |
| Pre-tax Income | 32,832 | 51,590 | 32,626 | 42,224 | 41,059 |
| Income Tax | 7,924 | 10,548 | 3,243 | 9,280 | 7,862 |
| Net Income Continuous | 24,908 | 41,042 | 29,383 | 32,944 | 33,197 |
| Net Income | $24,908 | $41,042 | $29,383 | $32,944 | $33,197 |
| EPS Basic Total Ops | 0.49 | 0.81 | 0.58 | 0.65 | 0.65 |
| EPS Basic Continuous Ops | 0.49 | 0.81 | 0.58 | 0.65 | 0.65 |
| EPS Diluted Total Ops | 0.48 | 0.80 | 0.58 | 0.64 | 0.64 |
| EPS Diluted Continuous Ops | 0.48 | 0.80 | 0.57 | 0.64 | 0.64 |
| EBITDA(a) | $58,316 | $76,691 | $58,011 | $67,634 | $69,684 |